The effect of duloxetine in depression of menopose wome
Not Applicable
- Conditions
- depression of menopose women
- Registration Number
- JPRN-UMIN000017278
- Lead Sponsor
- Department of Obstetrics and Gynecology,Keio university school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with advanced renal function and liver dysfunction Patients with refractory glaucoma Patients who don not agree informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of depression
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie duloxetine's efficacy in JPRN-UMIN000017278 for menopausal depression?
How does duloxetine compare to SSRIs like paroxetine in treating menopausal depression per JPRN-UMIN000017278?
Which biomarkers predict duloxetine response in menopausal depression as studied in JPRN-UMIN000017278?
What adverse events are reported with duloxetine in JPRN-UMIN000017278 for menopausal depression and how are they managed?
Are there combination therapies with duloxetine and HRT for menopausal depression in JPRN-UMIN000017278?